First Trust Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $459K | Sell |
|
|||||
|
2025
Q1 | $4.36M | Buy |
|
|||||
|
2024
Q4 | $818K | Buy |
|
|||||
|
2024
Q3 | $499K | Sell |
|
|||||
|
2024
Q2 | $4.75M | Sell |
|
|||||
|
2024
Q1 | $23.9M | Buy |
|
|||||
|
2023
Q4 | $5.62M | Sell |
|
|||||
|
2023
Q3 | $15.1M | Buy |
|
|||||
|
2023
Q2 | $7.04M | Buy |
|
|||||
|
2023
Q1 | $3.19M | Sell |
|
|||||
|
2022
Q4 | $2.73M | Buy |
|
|||||
|
2022
Q3 | $1.72M | Sell |
|
|||||
|
2022
Q2 | $2.87M | Buy |
|
|||||
|
2022
Q1 | $2.94M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $1.54M | Sell |
|
|||||
|
2019
Q4 | $2.15M | Buy |
|
|||||
|
2019
Q3 | $1.59M | Buy |
|